gilead.com is a domain that was created on 1995-05-27,making it 29 years ago. It has several subdomains, such as investors.gilead.com , among others.
Description:Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative...
Discover gilead.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 66.401 KB |
Page Load Time: 0.035502 Seconds |
Website IP Address: 40.70.27.35 |
Covid-19 and the Social Sciences - Covid-19 and the Social Sciences - Social Science Research Counci covid19research.ssrc.org |
Land Resources and Environmental Sciences - Land Resources and Environmental Sciences | Montana Stat landresources.montana.edu |
Jobs at Integra Life Sciences | Careers at Integra Life Sciences | | Apply Online jobs.integralife.com |
Faculty of Health Sciences - Faculty of Health Sciences fsk.unisel.edu.my |
College of Sciences | College of Sciences | Georgia Institute of Technology | Atlanta, GA cos.gatech.edu |
Welcome to Augustus C. Long Health Sciences Library | Augustus C. Long Health Sciences Library library.cumc.columbia.edu |
Home | Cognitive Sciences | UCI Social Sciences cogsci.uci.edu |
The College of Arts & Sciences has become two different colleges! | College of Arts & Sciences | Eas cas.eku.edu |
College of Arts and Sciences - College of Arts and Sciences | University of South Carolina artsandsciences.sc.edu |
Mathematical Sciences Home Pages--College of Liberal Arts & Sciences, The University of Iowa homepage.cs.uiowa.edu |
Welcome to Strauss Health Sciences Library | Strauss Health Sciences Library hslibrary.ucdenver.edu |
Gilead Sciences, Inc. - Investor Relations investors.gilead.com |
Gilead Consent advancingaccessconsent.iassist.com |
Gilead Ministry gmcfam.thechurchco.com |
Gilead Sciences, Inc. https://www.gilead.com/ |
Gilead Discovery Path https://www.gilead.com/discoverypath |
GADI2 External https://gadi2.gilead.com/ |
Stories @ Gilead https://stories.gilead.com/ |
About Us | Gilead https://www.gilead.com/our-company/about-us |
U.S. Patient Access | Gilead https://www.gilead.com/purpose/medication-access/us-patient-access |
Careers at Gilead - Gilead Sciences https://www.gilead.com/careers/careers-at-gilead |
Gilead Sciences, Inc. - Investor Relations https://investors.gilead.com/overview/default.aspx |
Leadership | Gilead https://www.gilead.com/our-company/leadership |
Medicines | Gilead https://www.gilead.com/science-and-medicine/medicines |
Gilead Sciences, Inc. - Events & Presentations https://investors.gilead.com/events-and-presentations/default.aspx |
Gilead Sciences Announces Fourth Quarter and Full Year 2023 Financial ... https://www.gilead.com/news-and-press/press-room/press-releases/2024/2/gilead-sciences-announces-fourth-quarter-and-full-year-2023-financial-results |
Virology, Oncology and Inflammation Pipeline | Gilead https://www.gilead.com/science-and-medicine/pipeline |
Gilead EU Expense Report: Guidelines for Reimbursement https://reimbursementseu.gilead.com/ |
Password Management Client https://partnersreset.gilead.com/ |
A gilead.com. 1109 IN A 40.70.27.35 |
MX gilead.com. 2433 IN MX 10 mxb-002ff601.gslb.pphosted.com. |
NS gilead.com. 20486 IN NS udns2.cscdns.uk. |
SOA gilead.com. 2057 IN SOA udns1.cscdns.net. hostmaster.netnames.net. 2018083056 28800 7200 1209600 3600 |
Date: Tue, 14 May 2024 13:03:29 GMT |
Content-Type: text/html; charset=utf-8 |
Transfer-Encoding: chunked |
Connection: keep-alive |
Cache-Control: no-cache, no-store |
Expires: -1 |
Pragma: no-cache |
Set-Cookie: ASP.NET_SessionId=5d50i0xtvlaflzsnr2k4dzui; path=/; secure; HttpOnly; SameSite=Lax, ASP.NET_SessionId=5d50i0xtvlaflzsnr2k4dzui; path=/; secure; HttpOnly; SameSite=Lax, SC_ANALYTICS_GLOBAL_COOKIE=f52c19a8ddf74b0eb84ee99e33edcebb|False; expires=Fri, 12-May-2034 13:03:29 GMT; path=/; secure; HttpOnly, __RequestVerificationToken=sdvQDnax1MCh53gW57QOqaaXyMeuOEYsJCS2jClG81UQlqo7o51eANXzvUgT2yxAupr2800jix1sigAQVA7eNbfSlVBJFZ9IQVtzLsNCLG41; path=/; secure; HttpOnly, ARRAffinity=25818f7a4137a42c02225abe913505506469b332b78b4cd6eaadab368c5b6fb3;Path=/;HttpOnly;Secure;Domain=wwwam.gilead.com, ARRAffinitySameSite=25818f7a4137a42c02225abe913505506469b332b78b4cd6eaadab368c5b6fb3;Path=/;HttpOnly;SameSite=None;Secure;Domain=wwwam.gilead.com |
Vary: Accept-Encoding |
Strict-Transport-Security: max-age=31536000; includeSubDomains; preload |
X-Frame-Options: SAMEORIGIN |
Request-Context: appId=cid-v1:2083eda3-a631-4047-bffb-fa6be1b6d0aa |
CF-Cache-Status: DYNAMIC |
Server: cloudflare |
CF-RAY: 883b16adb826936c-SEA |
charset="utf-8"/ |
content="width=device-width, initial-scale=1, shrink-to-fit=no" name="viewport"/ |
content="ie=edge" http-equiv="X-UA-Compatible"/ |
content="telephone=no" name="format-detection"/ |
content="Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines." name="description" |
content="summary" name="twitter:card" |
content="Gilead Sciences, Inc." property="og:title" |
content="Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines." property="og:description" |
content="https://wwwam.gilead.com/-/media/gilead-corporate/images/og/gilead_logo.jpg" property="og:image"/ |
Ip Country: United States |
City Name: Boydton |
Latitude: 36.6534 |
Longitude: -78.375 |
Sorry, your browser does not support JavaScript! Medicine Questions Report an Adverse Event Investors Contact Global Operations North America Canada Mexico USA South America Argentina Brazil Colombia Asia China Mainland Hong Kong India Japan Korea Singapore Taiwan Middle East Israel Saudi Arabia Türkiye United Arab Emirates Africa South Africa Australia Australia and New Zealand Europe Austria Belgium and Luxembourg Czech Republic & Slovakia Denmark Finland France Germany Greece Iceland Ireland Italy Netherlands Norway Poland & The Baltics Portugal Romania Russia Spain Sweden Switzerland United Kingdom Our CompanyLeadership U.S. Public Policy Engagement Policies and Disclosures Supplier Information U.S. Locations Our Purpose Partnerships and Community Corporate Giving Gilead Foundation Inclusion and Diversity Environmental, Social, Governance (ESG) Sustainability Advancing Global Health Health Equity Medication Access Science & Medicine Our Therapeutic Areas Medicines Pipeline Research Clinical Trials Diversity in Clinical Trials News and Press Events Stories Newsroom Company Statements Annual Reports Careers Careers at Gilead Our Culture Meet Our Employees Inclusion and Diversity in Hiring Compensation, Benefits and Wellbeing Our Global Footprint Early Career Opportunities Postdoctoral Fellowships Hiring Events Talent Community Sign-up Utility Privacy Statements Terms Of Use Social Media Guidelines Sitemap BACK TOLeadership Governance and Committees BACK TOU.S. Public Policy Engagement Political Contributions Archives BACK TOPolicies and Disclosures Policies Disclosures BACK TOSupplier Information Supplier Enablement Resources Supplier Inclusion BACK TOPartnerships and Community COMPASS Initiative HepConnect HIV Age Positively Setting the P.A.C.E. Toward Health Equity for Black People Impacted by TNBC Toward Health Equity Oncology Grant RADIAN TRANScend Zeroing In: Ending the HIV Epidemic Zeroing In: Latin America & The Caribbean (LAC) Region BACK TOCorporate Giving What We Fund Funding Requests BACK TOGilead Foundation Creating Possible Fund BACK TOEnvironmental, Social, Governance (ESG) Reporting U.N. Global Compact BACK TOSustainability Our Business Is Sustainable Performance BACK TOAdvancing Global Health COVID-19 HCV Elimination BACK TOMedication Access U.S. Patient Access Global Access Authorized Distributors BACK TOOur Therapeutic Areas Virology Oncology Inflammation BACK TOResearch Research Scholars Program Compassionate Use Community Based Participatory Research (CBPR) Investigator-Sponsored Research BACK TONewsroom Press Releases Media Inquiries BACK TOEarly Career Opportunities Internship Program BACK TOPrivacy Statements Consumer Health Data Privacy Policy Cookie Statement Global Applicant Privacy Statement Healthcare Professional Privacy Notice - U.S. only Healthcare Professional Privacy Notice BACK TONorth America Canada Mexico USA South America Argentina Brazil Colombia Asia China Mainland Hong Kong India Japan Korea Singapore Taiwan Middle East Israel Saudi Arabia Türkiye United Arab Emirates Africa South Africa Australia Australia and New Zealand Europe Austria Belgium and Luxembourg Czech Republic & Slovakia Denmark Finland France Germany Greece Iceland Ireland Italy Netherlands Norway Poland & The Baltics Portugal Romania Russia Spain Sweden Switzerland United Kingdom BACK TOContact Request Medicines Information Report an Adverse Event Partnership Request Report a Compliance Concern Search Term Medicine Questions Report an Adverse Event Investors Contact Global Operations Toggle Inner Dropdown BACK TOGoogle.com Creating a Healthier World for All People Through innovation, growth and impact, our vision is to create a healthier world for all people. Our 2023 Environmental Social Governance Impact Report captures how we’re driving positive change. Our Purpose Scientific Innovation We discover, develop and deliver medicines for the world’s most devastating diseases, from viruses to cancer to inflammatory conditions. Access & Health Equity We’re partnering with communities around the world to remove societal barriers to care, improve health equity and make our medicines available to those who need them most. Our People & Culture We foster an environment of inclusion and growth where our 17,000+ employees around the world are empowered to make a real impact. We’ve been taking on the world’s biggest health challenges for more than 35 years. We continue to set and achieve ambitious goals to create a healthier world for all people. Our Mission Recent Stories Access and Health Equity Native Health Navigator Program Connects Tribes to Cancer Care Stories@Gilead - April 24, 2024 - 4 min read Access and Health Equity Gilead Helps Put African Nation on Path to Eliminate Hepatitis C Stories@Gilead - March 27, 2024 - 1 min read Access and Health Equity Gilead’s FOCUS Program Helps Zero In on Early HIV Detection Stories@Gilead - March 21, 2024 - 2 min read Recent News May 09, 2024 Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program May 07, 2024 Gilead and Kite Oncology to Highlight Broad and Diverse Oncology Portfolio at ASCO 2024 Join Our Team We’re Hiring © 1996-2024 All rights reserved. AREAS OF INTEREST Careers Environmental, Social, Governance (ESG) Medicines Partnerships and Community Pipeline Stories@Gilead INFORMATION Contact Us Investor Calls Press Room Report an Adverse Event Report a Compliance Concern Sitemap LEGAL Cookie Statement Modern Slavery Act Statement Privacy Statement Consumer Health Data Privacy Policy Public Policy Engagement Social Media Guidelines Terms of Use FOLLOW US Headline Close × Intersititial body copy Ok...
Domain Name: GILEAD.COM Registry Domain ID: 3896485_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2023-05-22T05:07:31Z Creation Date: 1995-05-27T04:00:00Z Registry Expiry Date: 2024-05-26T04:00:00Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited Domain Status: serverTransferProhibited https://icann.org/epp#serverTransferProhibited Domain Status: serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited Name Server: UDNS1.CSCDNS.NET Name Server: UDNS2.CSCDNS.UK DNSSEC: signedDelegation DNSSEC DS Data: 50181 13 2 EB4D7B459B7861963F5C589B8C3D300C0D89B1D6E0596C4E5FEB800D2F4A66A8 DNSSEC DS Data: 50181 13 1 3800DF30AA77948D7E0C0F07114C8DCD5A5B6022 >>> Last update of whois database: 2024-05-17T20:07:38Z <<<